跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KADIAN MORPHINE SULFATE 10 mg capsule - sustained release bottle - TGA Drug Approval Details
Approvals
/
TGA
/
KADIAN MORPHINE SULFATE 10 mg capsule - sustained release bottle
Approved
STANDARD
KADIAN MORPHINE SULFATE 10 mg capsule - sustained release bottle
Mayne Pharma International Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
8ee0d7cf0cd6086e
Company
Mayne Pharma International Pty Ltd
Type
Standard
Approval Details
Approval Id
8ee0d7cf0cd6086e
Product Name
KADIAN MORPHINE SULFATE 10 mg capsule - sustained release bottle
Artg Id
92013
Artg Name
KADIAN MORPHINE SULFATE 10 mg capsule - sustained release bottle
Sponsor
Mayne Pharma International Pty Ltd
Company Detail Path
/organization/mayne-pharma-international-pty-ltd
Artg Date
2002-11-26
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
8ee0d7cf0cd6086e
Type
Standard
Back to TGA Approvals
